Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GT103 |
Trade Name | |
Synonyms | GT-103|GT 103 |
Drug Descriptions |
GT103 inhibits CFH, which potentially induces complement-dependent tumor cell killing, increases antitumor immune response, and decreases tumor growth (J Clin Oncol 41, 2023 (suppl 16; abstr 9128)). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C176771 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GT103 | GT103 | 0 | 1 |
GT103 + Pembrolizumab | GT103 Pembrolizumab | 0 | 1 |